The already mentioned ANRIL is an antisense lncRNA originates from the INK4B-ARF-INK4A locus, which contains three tumour suppressor genes, and it is overexpressed in prostate cancer tissues. The gene discussed is CDKN2B-AS1; the disease is prostate carcinoma.